Ariad Pharma (ARIA) Misses Q1 Loss Views by 3c
Tweet Send to a FriendGet Alerts ARIA Hot Sheet
Price: $18.43 +5.13%
EPS Growth %: -24.1%
Financial Fact:
Interest expense: -41K
Today's EPS Names:
NED, OESX, WSTL, More
EPS Growth %: -24.1%
Financial Fact:
Interest expense: -41K
Today's EPS Names:
NED, OESX, WSTL, More
Trade ARIA Now!
Ariad Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $81 thousand versus the consensus estimate of $300 thousand.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- LTX-Credence Corp (LTXC) Misses Q3 EPS by 2c; Issues Weak Q4 Outlook
- UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
